With more than 40 years’ experience, Insud Pharma has become an established, global group in the pharmaceutical industry, with a continuous growth and diversification. All of this to achieve the mission of providing accessible, effective, and high quality treatment, developing new and better, solutions and improving the health of millions of people all over, the world. Insud Pharma has a presence at every echelon of the chemical-pharmaceutical industry. Its activities are carried out through three synergistic business areas: industrial, branded and biotechnology.   Chemo is a global leader in R&D and manufacturing for over 100 value-added active pharmaceutical ingredients and more than 50 medicines with over 200 different product presentations. Its produces its own APls, as well as its own formulation patents for all major treatment areas. CHEMO’s facilities include five chemical plants in Italy, Spain, Argentina and India as well as four pharmaceutical facilities in Spain and one in India, all of which are fully compliant with GMP regulations and FDA and EMA quality standards. Coordinated out of its central headquarters, the company performs a wide range of commercial activities through its local offices, serving 1,115 customers in 96 countries worldwide, and is fully committed to active engagement with customers and to providing value in our business relationships.   Exeltis is a leading player in branded medicines. Now a top 5 name in Women´s Health, the company has expanded into other physician-driven therapeutic areas including Central Nervous System, Respiratory, Dermatology and Ophthalmology. In Women´s Health, the company is fully committed to innovation and partnership. Already a leader in contraception, the company has expanded its focus to encompass diseases with significant unmet patient needs, such as endometriosis and menopause. With a rapidly developing product catalogue, Exeltis serves patients and healthcare professionals all over the gl